&w=3840&q=100)
US Bill lowers remittance tax from 5% to 3.5% for non-US citizens
The Donald Trump administration has lowered the proposed remittance tax rate it plans to impose on funds sent abroad by non-US citizens, including to India, from 5 per cent to 3.5 per cent. The change was introduced through an amendment to the 'One Big Beautiful Bill', which was passed by the US House of Representatives on Thursday. Non-US citizens include H-1B, L-1, and F-1 visa holders, as well as green card holders. US citizens and nationals are exempt from this tax. The Bill will now head to the Republican-majority Senate for final approval before it can be enacted into law. The original version of the Bill — spanning major reforms in income tax, health care, corporate taxation, and federal debt — included a 5 per cent excise duty on outward remittances, to be paid by the sender. It drew concern from immigrant communities and experts, especially given the volume of remittances flowing from the US to countries like India and Mexico. A government official speaking on condition of anonymity said the Bill if enacted, will have an impact on remittances into the country. 'The government has not made an assessment yet. No discussion has happened whether its removal can be a demand under the proposed India-US bilateral trade agreement,' the official said. India is the largest recipient of remittances from the US. It received $32.9 billion in 2023-24, with a 27.7 per cent share in the country's inward remittances, according to the Reserve Bank of India data. Overall, such remittances have more than doubled from $55.6 billion in 2010-11 to $118.7 billion in 2023-24. 'In the short term, we expect remittances to India to spike before the effective date of January 1, 2026. We may also see a shift of some remittances from formal to informal channels,' said Lloyd Pinto, Partner - US Tax at Grant Thornton Bharat.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
9 minutes ago
- Indian Express
Torrent to buy 46.39 pc stake in JB Chemicals for Rs 11,917 crore
In a significant acquisition in the pharmaceutical sector, Torrent Pharmaceuticals Ltd on Sunday entered into definitive agreements to acquire controlling stake of 46.39 per cent stake in J. B. Chemicals and Pharmaceuticals from global investment firm KKR for Rs 11,917 crore at a price of Rs 1,600 per share. Torrent will also make a mandatory open offer to acquire another 26 per cent of JB Pharma shares from public shareholders at an open offer price of Rs 1,639.18 per share. After the open offer, the total cost of acquisition will come to Rs 13,556 crore. The acquisition was made at an equity valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities. The transaction marks a significant step in Torrent's ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO (contract development and manufacturing organization) capabilities. As per the approval given by the board of directors of both companies, after the merger of JB Pharma with Torrent, every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent. In addition to this, Torrent has also expressed its intent to acquire up to 2.80% of equity shares from certain employees of JB Pharma at the same price per share as KKR. The merger between Torrent and JB Pharma will be through a scheme of arrangement. KKR, a US-based private equity giant, acquired about 54 per cent stake in JB Chemicals and Pharmaceuticals, one of the oldest pharma companies in India, for Rs 3,100 crore in July 2020. It acquired the stake from the founding Mody family at a purchase price of Rs 745 per share and made an open offer for an additional 26 per cent of the company. Samir Mehta, Executive chairman, Torrent, said: 'Torrent's deep India presence and JB Pharma's fast growing India business, combined with the CDMO and international footprint offers immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, and build a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.' Torrent Pharma, which has a market valuation of Rs 1.13 lakh crore, closed higher by 3.68 per cent at Rs 3344.40 on the BSE on Friday. JB Chemicals, with a market capitalisation of Rs 28,080 crore, reported a revenue of Rs 3,722 crore in FY25. Its shares closed 2.72 per cent higher at Rs 1799.35 on the BSE. Torrent Pharma, with annual revenues of more than Rs 11,500 crore, is the flagship company of the Torrent Group, with group revenues of Rs 45,000 crore. It is amongst the top 5 in the therapeutics segments of cardiovascular (CV), gastro Intestinal (GI), central nervous system (CNS) and cosmo-dermatology. It is a specialty-focused company with 76 per cent of its revenues in India from chronic and sub- chronic therapies. It has presence in 50 plus countries. Torrent has 8 manufacturing facilities, of which 5 are USFDA approved. JB Pharma is one of the fastest growing pharmaceutical companies in India and a leading player in the hypertension segment. Besides its strong India presence, which accounts for majority of its revenue, its other two home markets are Russia and South Africa. In India, the company has six brands among the top 300 IPM brands in the country. It has eight state-of-the-art manufacturing facilities in India including a dedicated manufacturing facility for lozenges
Time of India
10 minutes ago
- Time of India
Globalisation 2.0: India well positioned to emerge as one of new centres of gravity: Anand Mahindra
A growing wave of protectionism is challenging decades of liberal trade order, dramatically highlighted by the Trump's tariffs, but economic nationalism does not spell the death of globalisation rather it heralds its rebirth, presenting an opportunity for India to emerge as a vital player, according to M&M Ltd Chairman Anand Mahindra . In his address to shareholders in Mahindra & Mahindra (M&M) Annual Report for 2024-25, Mahindra, said "India, too, will face challenges" due to the ongoing global turmoil in the midst of a growing wave of protectionism. He said globalisation is evolving and the US market centrality and China-centric supply chains are being replaced by multi-polar, regional collaborations. As structural and political uncertainties diminish US dominance, alternative capital destinations are emerging, Mahindra noted. Similarly, global supply chains are diversifying away from China, creating new trade partnerships. Lower tariff barriers among regional partners may emerge, boosting free trade and reshaping international trade centres of gravity. Live Events "Ironically, the US shift toward de-globalisation may lead to a new avatar of globalisation 'multi-polar, regional, and driven by domestic imperatives. In such shifting sands, I believe India is well-positioned to emerge as one of the new centres of gravity," Mahindra asserted. He further said, "We are a stable democracy, generally regarded as a trustworthy partner, and are bolstered by a strong military that is not politicised." Referring to Pakistan, he said, "The situation with our provocative neighbour is always volatile, but I am optimistic that we can demonstrate the limits to our tolerance without impeding our path to economic ascendance." These implications offer a portal to a stronger future for India and Indian companies, he noted, adding "but the future remains uncertain." On how the Mahindra group should navigate these turbulent waters, he said, "Whether it be a country or a business, the winners will be the ones who can successfully navigate uncertainty and ambiguity -- the ones who are resilient." Referring to the current global situation, he said it remains fluid. Recent US-China tariff talks and strengthened trade ties with the UK suggest a pragmatic layer to US trade policy, combining protectionism with strategic global engagement. "However, there remains a strong likelihood of significant decoupling between the US and China, he added. Whatever the outcome, it is apparent that many nations will have to swallow some "poison", Mahindra said adding, "international trade has already slowed amidst heightened uncertainty and dampened investor confidence." Noting that industries reliant on global supply chains -- like electronics and consumer goods -- will bear the brunt of rising input costs, Mahindra said "countries deeply integrated into global trade networks must rethink dependencies and diversify sourcing." Established geopolitical alliances are being realigned, ushering in a new era of economic nationalism. Businesses worldwide will adapt by localising operations, re-engineering supply chains, and exploring alternate markets. "India, too, will face challenges. Our large trade deficit, vulnerabilities in certain sectors, increased competition among nations, and uncertainties affecting GDP aspirations are all challenges that must be met," Mahindra said. He pointed out that key industries, such as steel and aluminium, could face headwinds, and export volumes may be impacted. "The challenge will be to minimise the adverse effects, akin to how Lord Shiva confined the poison to his throat without letting it spread (during Samudra Manthan)," Mahindra said. He cautioned against focusing solely on mitigation saying it reflects a reactive mindset. "Instead, we can proactively view this as an opportunity to enable some 'Amrit' to emerge," he said, suggesting to "seize this challenge as an opportunity to accelerate economic growth exhorting private enterprise to play a pivotal role in this transformation. Mahindra noted that China's adversarial stance may create opportunities for India to position itself as a supply chain alternative -- a long-term goal for Indian business. "Innovation and R&D could receive renewed focus, while manufacturing could once again take centre stage. Restrictions on China and high tariffs for other competing countries could open new markets for Indian goods," he said. While the potential exists, he said achieving it will require a concerted focus on manufacturing and a palpable increase in private investment. "Speed and agility are essential, as countries like the Philippines and Vietnam are already touting themselves as future manufacturing hubs. We must act swiftly and strategically to secure our share of the Amrit," Mahindra said.
Mint
15 minutes ago
- Mint
Wall Street week ahead: Investors to focus on jobs data, manufacturing & services PMIs, Trump's ‘One Big Beautiful Act'
Wall Street investors in the week ahead are expected to focus on key economic data, including monthly non-farm payrolls report, and on Senate Republicans' push to pass US President Donald Trump's 'One Big Beautiful Act' legislation. The Republicans are planning to vote on the proposed budget reconciliation bill over the weekend. It was passed in the House of Representatives on May 22, 2025. Market participants will keenly monitor the non-farm payrolls data for June, to be released by the Bureau of Labor Statistics on Thursday, for clues on the US Federal Reserve's interest rate path ahead. Among other economic data, the markets will see manufacturing and services PMIs for June, TBA auto sales, and factory orders for May. On June 30 (Monday), data on Chicago Business Barometer (PMI) for June will be released. On July 1 (Tuesday), separate reports on S&P final US manufacturing PMI for June, job openings for May, ISM manufacturing for June, and TBA auto sales for June will be released. On July 2 (Wednesday), data on ADP employment for June will be released. On July 3 (Thursday), separate reports on US employment report for June, US trade deficit for May, S&P final US services PMI for June, factory orders for May, and ISM services June will be released. Following companies are due to report first quarter results in the week ahead — Progress Software, Constellation Brands, MSC Industrial Direct Co., The Greenbrier Companies, and UniFirst Corporation. US stocks closed at an all-time high on Friday as trade deal hopes fueled investor risk appetite and economic data helped solidify expectations for rate cuts from the Federal Reserve. The Dow Jones Industrial Average rose 432.43 points, or 1.00%, to 43,819.27, the S&P 500 gained 32.05 points, or 0.52%, to 6,173.07 and the Nasdaq Composite gained 105.55 points, or 0.52%, to 20,273.46. In the bond market, the yield on the 10-year Treasury rose to 4.27% from 4.24%. The 2-year Treasury yield edged up to 3.74%.
